» Articles » PMID: 29716899

Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women's Health Initiative

Abstract

Background: The higher risk of heart failure (HF) in African-American and Hispanic women compared with white women is related to the higher burden of risk factors (RFs) in minorities. However, it is unclear if there are differences in the association between the number of RFs for HF and the risk of development of HF and death within racial/ethnic groups.

Methods And Results: In the WHI (Women's Health Initiative; 1993-2010), African-American (n=11 996), white (n=18 479), and Hispanic (n=5096) women with 1, 2, or 3+ baseline RFs were compared with women with 0 RF within their respective racial/ethnic groups to assess risk of developing HF or all-cause mortality before and after HF, using survival analyses. After adjusting for age, socioeconomic status, and hormone therapy, the subdistribution hazard ratio (95% confidence interval) of developing HF increased as number of RFs increased (<0.0001, interaction of race/ethnicity and RF number =0.18)-African-Americans 1 RF: 1.80 (1.01-3.20), 2 RFs: 3.19 (1.84-5.54), 3+ RFs: 7.31 (4.26-12.56); Whites 1 RF: 1.27 (1.04-1.54), 2 RFs: 1.95 (1.60-2.36), 3+ RFs: 4.07 (3.36-4.93); Hispanics 1 RF: 1.72 (0.68-4.34), 2 RFs: 3.87 (1.60-9.37), 3+ RFs: 8.80 (3.62-21.42). Risk of death before developing HF increased with subsequent RFs (<0.0001) but differed by racial/ethnic group (interaction =0.001). The number of RFs was not associated with the risk of death after developing HF in any group (=0.25; interaction =0.48).

Conclusions: Among diverse racial/ethnic groups, an increase in the number of baseline RFs was associated with higher risk of HF and death before HF but was not associated with death after HF. Early RF prevention may reduce the burden of HF across multiple racial/ethnic groups.

Citing Articles

Racial and ethnic influences on carotid atherosclerosis: Epidemiology and risk factors.

Huang Y, Shi W, He Q, Tan J, Tong J, Yu B SAGE Open Med. 2024; 12:20503121241261840.

PMID: 39045542 PMC: 11265241. DOI: 10.1177/20503121241261840.


Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study.

Fazlalizadeh H, Khan M, Fox E, Douglas P, Adams D, Blaha M Circ Cardiovasc Imaging. 2024; 17(2):e015496.

PMID: 38377236 PMC: 10883604. DOI: 10.1161/CIRCIMAGING.123.015496.


Prioritizing the primary prevention of heart failure: Measuring, modifying and monitoring risk.

Patel R, Peesay T, Krishnan V, Wilcox J, Wilsbacher L, Khan S Prog Cardiovasc Dis. 2024; 82():2-14.

PMID: 38272339 PMC: 10947831. DOI: 10.1016/j.pcad.2024.01.001.


Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America.

Bozkurt B, Ahmad T, Alexander K, Baker W, Bosak K, Breathett K J Card Fail. 2023; 29(10):1412-1451.

PMID: 37797885 PMC: 10864030. DOI: 10.1016/j.cardfail.2023.07.006.


Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management.

Ilonze O, Free K, Shinnerl A, Lewsey S, Breathett K Heart Fail Clin. 2023; 19(3):379-390.

PMID: 37230651 PMC: 10614031. DOI: 10.1016/j.hfc.2023.02.009.


References
1.
Spahillari A, Talegawkar S, Correa A, Carr J, Terry J, Lima J . Ideal Cardiovascular Health, Cardiovascular Remodeling, and Heart Failure in Blacks: The Jackson Heart Study. Circ Heart Fail. 2017; 10(2). PMC: 5319800. DOI: 10.1161/CIRCHEARTFAILURE.116.003682. View

2.
Rossouw J, Prentice R, Manson J, Wu L, Barad D, Barnabei V . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007; 297(13):1465-77. DOI: 10.1001/jama.297.13.1465. View

3.
Eaton C, Abdulbaki A, Margolis K, Manson J, Limacher M, Klein L . Racial and ethnic differences in incident hospitalized heart failure in postmenopausal women: the Women's Health Initiative. Circulation. 2012; 126(6):688-96. PMC: 4618499. DOI: 10.1161/CIRCULATIONAHA.111.066688. View

4.
Cuspidi C, Sala C, Negri F, Mancia G, Morganti A . Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2011; 26(6):343-9. DOI: 10.1038/jhh.2011.104. View

5.
Anderson G, Manson J, Wallace R, Lund B, Hall D, Davis S . Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003; 13(9 Suppl):S5-17. DOI: 10.1016/s1047-2797(03)00043-7. View